Dr. Emily Mcdonald

Biography

Emily McDonald is a clinician-scientist and general internist epidemiologist. She serves as an Associate Professor in the Department of Medicine at McGill University, where she also holds the position of Associate Chair for Quality and Safety. Dr. McDonald is an attending physician at the McGill University Health Center and a scientist at the Research Institute of the McGill University Health Centre (RI-MUHC). After completing her medical education, she undertook a fellowship in Epidemiology at McGill University, along with post-graduate training in patient safety and quality improvement at Sunnybrook Health Sciences Centre and Harvard T. H. Chan School of Public Health. As the Director of the Canadian Medication Appropriateness and Deprescribing Network, Dr. McDonald focuses her research on interventions concerning polypharmacy, medication safety, and dosing strategies. She has published numerous studies on the appropriate use of hospital resources and treatments in high-impact peer-reviewed journals, particularly emphasizing safer prescribing for older adults. In 2020-2021, she led several high-profile studies related to COVID-19. Dr. McDonald actively supervises graduate students in the field of medication safety and optimization, having received funding from CIHR, the Centre for Ageing Brain Health Innovation, the Canadian Frailty Network, and the McGill Interdisciplinary Initiative on Infection and Immunity (MI-4).

Research Interests